In a story about lesser-known provisions of the March 2020 CARES Act, Erick Turner, M.D., says a new user fee system for over-the-counter drugs “will create a conflict of interest, putting pressure on the FDA to answer more to industry and less to the taxpayer.”
In a story about updated screening recommendations for those at risk for Hepatitis B virus, Aaron Caughey, M.D., Ph.D., says “screening in those at increased risk consistently leads to better health outcomes.”
A story about potential treatments and vaccines under development cites ongoing work by Michael Cohen, Ph.D., and others examining the metabolism cofactor nicotinamide adenine dinucleotide’s role in COVID-19 infections.
Mark Slifka, Ph.D., is quoted in a story about a newly developed vaccine that appears to be effective in monkeys. “This provides strong evidence that the virus is not mutating in a way that would make it resistant to a COVID-19 vaccine. Good to know.”
News coverage of announcement by Gov. Kate Brown about new OHSU-led statewide study to track, test and precisely map the novel coronavirus in real time.
Fennec Pharmaceuticals announces pricing of public offering for PEDMARK, a unique formulation of sodium thiosulfate that, based on research conducted at OHSU, can help to prevent pediatric ototoxicity caused by cisplatin chemotherapy.